Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: MYCN AMPLIFICATION, . Treffer: 6

2016

Bogen, D; Brunner, C; Walder, D; Ziegler, A; Abbasi, R; Ladenstein, RL; Noguera, R; Martinsson, T; Amann, G; Schilling, FH; Ussowicz, M; Benesch, M; Ambros, PF; Ambros, IM The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Int J Cancer. 2016; 139(1):153-163 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

von Bueren, AO; Kortmann, RD; von Hoff, K; Friedrich, C; Mynarek, M; Müller, K; Goschzik, T; Zur Mühlen, A; Gerber, N; Warmuth-Metz, M; Soerensen, N; Deinlein, F; Benesch, M; Zwiener, I; Kwiecien, R; Faldum, A; Bode, U; Fleischhack, G; Hovestadt, V; Kool, M; Jones, D; Northcott, P; Kuehl, J; Pfister, S; Pietsch, T; Rutkowski, S Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic Parameters.
J Clin Oncol. 2016; 34(34):4151-4160
Web of Science PubMed FullText FullText_MUG

 

2001

Ambros, PF; Ambros, IM; Kerbl, R; Luegmayr, A; Rumpler, S; Ladenstein, R; Amann, G; Kovar, H; Horcher, E; De Bernardi, B; Michon, J; Gadner, H Intratumoural heterogeneity of 1p deletions and MYCN amplification in neuroblastomas.
Med Pediatr Oncol. 2001; 36(1):1-4
Web of Science PubMed FullText FullText_MUG

 

Ladenstein, R; Ambros, IM; Pötschger, U; Amann, G; Urban, C; Fink, FM; Schmitt, K; Jones, R; Slociak, M; Schilling, F; Ritter, J; Berthold, F; Gadner, H; Ambros, PF Prognostic significance of DNA di-tetraploidy in neuroblastoma.
Med Pediatr Oncol. 2001; 36(1):83-92
Web of Science PubMed FullText FullText_MUG

 

1998

Erttmann, R; Tafese, T; Berthold, F; Kerbl, R; Mann, J; Parker, L; Schilling, F; Ambros, P; Christiansen, H; Favrot, M; Kabisch, H; Hero, B; Philip, T 10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE).
Eur J Cancer. 1998; 34(9):1391-1397
Web of Science PubMed FullText FullText_MUG

 

1995

Ambros, PF; Ambros, IM; Strehl, S; Bauer, S; Luegmayr, A; Kovar, H; Ladenstein, R; Fink, FM; Horcher, E; Printz, G Regression and progression in neuroblastoma. Does genetics predict tumour behaviour?
Eur J Cancer. 1995; 31A(4):510-515
Web of Science PubMed FullText FullText_MUG Google Scholar

 

© Med Uni Graz Impressum